{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:29:09Z","timestamp":1773300549397,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10157-011-0492-3","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T16:16:46Z","timestamp":1320250606000},"page":"25-29","source":"Crossref","is-referenced-by-count":19,"title":["Towards developing new strategies to reduce the adverse side-effects of nonsteroidal anti-inflammatory drugs"],"prefix":"10.1007","volume":"16","author":[{"given":"Noritaka","family":"Kawada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Furumatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Takabatake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enyu","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"492_CR1","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1073\/pnas.85.5.1412","volume":"85","author":"DL DeWitt","year":"1988","unstructured":"DeWitt DL, Smith WL. Primary structure of prostaglandin G\/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA. 1988;85:1412\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"492_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-2776(08)60430-7","volume":"62","author":"WL Smith","year":"1996","unstructured":"Smith WL, Dewitt DL. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol. 1996;62:167\u2013215.","journal-title":"Adv Immunol"},{"key":"492_CR3","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/978-1-59259-963-9_58","volume-title":"Principles of molecular medicine","author":"CS Wilcox","year":"2006","unstructured":"Wilcox CS. Nitric oxide synthase and cyclooxygenase in the kidney. In: Ruge MS, Patterson C, editors. Principles of molecular medicine. 2nd ed. Totowa: Hunana Press Inc; 2006. p. 606\u201312.","edition":"2"},{"key":"492_CR4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.amjcard.2009.01.014","volume":"103","author":"ME Farkouh","year":"2009","unstructured":"Farkouh ME, Greenberg BP. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol. 2009;103:1227\u201337.","journal-title":"Am J Cardiol"},{"key":"492_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(06)62001-3","volume":"162","author":"CM Blatteis","year":"2007","unstructured":"Blatteis CM. The onset of fever: new insights into its mechanism. Prog Brain Res. 2007;162:3\u201314.","journal-title":"Prog Brain Res"},{"key":"492_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/26233","volume":"395","author":"F Ushikubi","year":"1998","unstructured":"Ushikubi F, Segi E, Sugimoto Y, Murata T, Matsuoka T, Kobayashi T, Hizaki H, Tuboi K, Katsuyama M, Ichikawa A, Tanaka T, Yoshida N, Narumiya S. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature. 1998;395:281\u20134.","journal-title":"Nature"},{"key":"492_CR7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/1096-9861(20001204)428:1<5::AID-CNE2>3.0.CO;2-M","volume":"428","author":"M Ek","year":"2000","unstructured":"Ek M, Arias C, Sawchenko P, Ericsson-Dahlstrand A. Distribution of the EP3 prostaglandin E2 receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness. J Comp Neurol. 2000;428:5\u201320.","journal-title":"J Comp Neurol"},{"key":"492_CR8","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1046\/j.1471-4159.2000.0742134.x","volume":"74","author":"J Zhang","year":"2000","unstructured":"Zhang J, Rivest S. A functional analysis of EP4 receptor-expressing neurons in mediating the action of prostaglandin E2 within specific nuclei of the brain in response to circulating interleukin-1beta. J Neurochem. 2000;74:2134\u201345.","journal-title":"J Neurochem"},{"key":"492_CR9","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.2741\/1458","volume":"9","author":"T Oka","year":"2004","unstructured":"Oka T. Prostaglandin E2 as a mediator of fever: the role of prostaglandin E (EP) receptors. Front Biosci. 2004;9:3046\u201357.","journal-title":"Front Biosci"},{"key":"492_CR10","first-page":"145","volume":"60","author":"W Gao","year":"2009","unstructured":"Gao W, Schmidtko A, Wobst I, Lu R, Angioni C, Geisslinger G. Prostaglandin D2 produced by hematopoietic prostaglandin D synthase contributes to LPS-induced fever. J Physiol Pharmacol. 2009;60:145\u201350.","journal-title":"J Physiol Pharmacol"},{"key":"492_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1744-8069-1-3","volume":"1","author":"T Moriyama","year":"2005","unstructured":"Moriyama T, Higashi T, Togashi K, Iida T, Segi E, Sugimoto Y, Tominaga T, Narumiya S, Tominaga M. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain. 2005;1:3.","journal-title":"Mol Pain"},{"key":"492_CR12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI23618","volume":"115","author":"H Reinold","year":"2005","unstructured":"Reinold H, Ahmadi S, Depner UB, Layh B, Heindl C, Hamza M, Pahl A, Brune K, Narumiya S, M\u00fcller U, Zeilhofer HU. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest. 2005;115:673\u20139.","journal-title":"J Clin Invest"},{"key":"492_CR13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-2952(01)00654-2","volume":"62","author":"A Ueno","year":"2001","unstructured":"Ueno A, Matsumoto H, Naraba H, Ikeda Y, Ushikubi F, Matsuoka T, Narumiya S, Sugimoto Y, Ichikawa A, Oh-ishi S. Major roles of prostanoid receptors IP and EP3 in endotoxin-induced enhancement of pain perception. Biochem Pharmacol. 2001;62:157\u201360.","journal-title":"Biochem Pharmacol"},{"key":"492_CR14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MOG.0b013e328331549f","volume":"25","author":"LH Lai","year":"2009","unstructured":"Lai LH, Chan FK. Nonsteroid anti-inflammatory drug-induced gastroduodenal injury. Curr Opin Gastroenterol. 2009;25:544\u20138.","journal-title":"Curr Opin Gastroenterol"},{"key":"492_CR15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/14740330903311023","volume":"8","author":"S Harirforoosh","year":"2009","unstructured":"Harirforoosh S, Jamali F. Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf. 2009;8:669\u201381.","journal-title":"Expert Opin Drug Saf"},{"key":"492_CR16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/sj.bjp.0706390","volume":"146","author":"P Gluais","year":"2005","unstructured":"Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol. 2005;146:834\u201345.","journal-title":"Br J Pharmacol"},{"key":"492_CR17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/cvr\/12.10.620","volume":"12","author":"GJ Dusting","year":"1978","unstructured":"Dusting GJ, Chapple DJ, Hughes R, Moncada S, Vane JR. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs. Cardiovasc Res. 1978;12:720\u201330.","journal-title":"Cardiovasc Res"},{"key":"492_CR18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/cvr\/cvm112","volume":"78","author":"EH Tang","year":"2008","unstructured":"Tang EH, Jensen BL, Skott O, Leung GP, Feletou M, Man RY, Vanhoutte PM. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovasc Res. 2008;78:130\u20138.","journal-title":"Cardiovasc Res"},{"key":"492_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0031-6997(25)06784-5","volume":"46","author":"RA Coleman","year":"1994","unstructured":"Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev. 1994;46:205\u201329.","journal-title":"Pharmacol Rev"},{"key":"492_CR20","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1074\/jbc.R600038200","volume":"282","author":"Y Sugimoto","year":"1994","unstructured":"Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem. 1994;282:11613\u20137.","journal-title":"J Biol Chem"},{"key":"492_CR21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-201X.2004.01329.x","volume":"181","author":"RC Harris","year":"2004","unstructured":"Harris RC, Zhang MZ, Cheng HF. Cyclooxygenase-2 and the renal renin-angiotensin system. Acta Physiol Scand. 2004;181:543\u20137.","journal-title":"Acta Physiol Scand"},{"key":"492_CR22","doi-asserted-by":"crossref","first-page":"F989","DOI":"10.1152\/ajprenal.00201.2005","volume":"289","author":"UG Friis","year":"2005","unstructured":"Friis UG, Stubbe J, Uhrenholt TR, Svenningsen P, N\u00fcsing RM, Sk\u00f8tt O, Jensen BL. Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells. Am J Physiol. 2005;289:F989\u201397.","journal-title":"Am J Physiol"},{"key":"492_CR23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1681\/ASN.V103647","volume":"10","author":"S Nielsen","year":"1999","unstructured":"Nielsen S, Kwon TH, Christensen BM, Promeneur D, Fr\u00f8ki\u00e6r J, Marples D. Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol. 1999;10:647\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"492_CR24","doi-asserted-by":"crossref","first-page":"F1093","DOI":"10.1152\/ajprenal.00119.2004","volume":"287","author":"BF Melvin","year":"2004","unstructured":"Melvin BF. Development of water transport in the collecting duct. Am J Physiol. 2004;287:F1093\u2013101.","journal-title":"Am J Physiol"},{"key":"492_CR25","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1172\/JCI39680","volume":"119","author":"JH Li","year":"2009","unstructured":"Li JH, Chou CL, Li B, Gavrilova O, Eisner C, Schnermann J, Anderson SA, Deng CX, Knepper MA, Wess J. A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus. J Clin Invest. 2009;119:3115\u201326.","journal-title":"J Clin Invest"},{"key":"492_CR26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00849259","volume":"1","author":"HW Seyberth","year":"1987","unstructured":"Seyberth HW, K\u00f6niger SJ, Rascher W, K\u00fchl PG, Schweer H. Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr Nephrol. 1987;1:491\u20137.","journal-title":"Pediatr Nephrol"},{"key":"492_CR27","doi-asserted-by":"crossref","first-page":"F818","DOI":"10.1152\/ajprenal.90253.2008","volume":"295","author":"J Chen","year":"2008","unstructured":"Chen J, Zhao M, He W, Milne GL, Howard JR, Morrow J, H\u00e9bert RL, Breyer RM, Chen J, Hao CM. Increased dietary NaCl induces renal medullary PGE2 production and natriuresis via the EP2 receptor. Am J Physiol. 2008;295:F818\u201325.","journal-title":"Am J Physiol"},{"key":"492_CR28","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1681\/ASN.2004070556","volume":"16","author":"RM N\u00fcsing","year":"2005","unstructured":"N\u00fcsing RM, Treude A, Weissenberger C, Jensen B, Bek M, Wagner C, Narumiya S, Seyberth HW. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome\/antenatal Bartter syndrome. J Am Soc Nephrol. 2005;16:2354\u201362.","journal-title":"J Am Soc Nephrol"},{"key":"492_CR29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/hc3401.093152","volume":"104","author":"F Cipollone","year":"2001","unstructured":"Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, Iezzi A, Ucchino S, Boccoli G, Saba V, Chiarelli F, Cuccurullo F, Mezzetti A. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability. Circulation. 2001;104:921\u20137.","journal-title":"Circulation"},{"key":"492_CR30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00045391-200103000-00003","volume":"8","author":"A Whelton","year":"2001","unstructured":"Whelton A, Fort JG, Puma JA, Normandin D, Bello AE, Verburg KM, SUCCESS VI Study Group. Cyclooxygenase-2\u2014specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther. 2001;8:85\u201395.","journal-title":"Am J Ther"},{"key":"492_CR31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0002-9149(02)02661-9","volume":"90","author":"A Whelton","year":"2002","unstructured":"Whelton A, White WB, Bello AE, Puma JA, Fort JG, SUCCESS-VII Investigators. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65\u00a0years of age with systemic hypertension and osteoarthritis. Am J Cardiol. 2002;90:959\u201363.","journal-title":"Am J Cardiol"},{"key":"492_CR32","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1172\/JCI117620","volume":"94","author":"RC Harris","year":"1994","unstructured":"Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest. 1994;94:2504\u201310.","journal-title":"J Clin Invest"},{"key":"492_CR33","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/019262339802600504","volume":"26","author":"KN Khan","year":"1998","unstructured":"Khan KN, Venturini CM, Bunch RT, Brassard JA, Koki AT, Morris DL, Trump BF, Maziasz TJ, Alden CL. Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity. Toxicol Pathol. 1998;26:612\u201320.","journal-title":"Toxicol Pathol"},{"key":"492_CR34","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1161\/01.HYP.0000166141.69081.80","volume":"45","author":"N Kawada","year":"2005","unstructured":"Kawada N, Solis G, Ivey N, Connors S, Dennehy K, Modlinger P, Hamel R, Kawada JT, Imai E, Langenbach R, Welch WJ, Wilcox CS. Cyclooxygenase-1 deficient mice have high sleep-to-awake ratios and renal vasoconstriction. Hypertension. 2005;45:1131\u20138.","journal-title":"Hypertension"},{"key":"492_CR35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/BJ20050451","volume":"391","author":"PO Hetu","year":"2005","unstructured":"Hetu PO, Riendeau D. Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain. Biochem J. 2005;391:561\u20136.","journal-title":"Biochem J"},{"key":"492_CR36","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1172\/JCI27540","volume":"116","author":"Y Cheng","year":"2006","unstructured":"Cheng Y, Wang M, Yu Y, Lawson J, Funk CD, Fitzgerald GA. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest. 2006;116:1391\u20139.","journal-title":"J Clin Invest"},{"key":"492_CR37","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI9523","volume":"105","author":"BF McAdam","year":"2000","unstructured":"McAdam BF, Mardini IA, Habib A, Burke A, Lawson JA, Kapoor S, FitzGerald GA. Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest. 2000;105:1473\u201382.","journal-title":"J Clin Invest"},{"key":"492_CR38","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1200\/JCO.2005.09.051","volume":"23","author":"JR Brown","year":"2005","unstructured":"Brown JR, DuBois RN. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol. 2005;23:2840\u201355.","journal-title":"J Clin Oncol"},{"key":"492_CR39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/5583","volume":"5","author":"CR Kennedy","year":"1999","unstructured":"Kennedy CR, Zhang Y, Brandon S, Guan Y, Coffee K, Funk CD, Magnuson MA, Oates JA, Breyer MD, Breyer RM. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med. 1999;5:217\u201320.","journal-title":"Nat Med"},{"key":"492_CR40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.ki.5001715","volume":"70","author":"S Vukicevic","year":"2006","unstructured":"Vukicevic S, Simic P, Borovecki F, Grgurevic L, Rogic D, Orlic I, Grasser WA, Thompson DD, Paralkar VM. Role of EP2 and EP4 receptor-selective agonists of prostaglandin E2 in acute and chronic kidney failure. Kidney Int. 2006;70:1099\u2013106.","journal-title":"Kidney Int"},{"key":"492_CR41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF00374216","volume":"421","author":"F Takemoto","year":"1992","unstructured":"Takemoto F, Cohen HT, Satoh T, Katz AI. Dopamine inhibits Na\/K-ATPase in single tubules and cultured cells from distal nephron. Pflugers Arch. 1992;421:302\u20136.","journal-title":"Pflugers Arch"},{"key":"492_CR42","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1074\/jbc.M805501200","volume":"284","author":"KR Hallows","year":"2009","unstructured":"Hallows KR, Wang H, Edinger RS, Butterworth MB, Oyster NM, Li H, Buck J, Levin LR, Johnson JP, Pastor-Soler NM. Regulation of epithelial Na+ transport by soluble adenylyl cyclase in kidney collecting duct cells. J Biol Chem. 2009;284:5774\u201383.","journal-title":"J Biol Chem"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-011-0492-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-011-0492-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-011-0492-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T18:13:10Z","timestamp":1741889590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-011-0492-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["492"],"URL":"https:\/\/doi.org\/10.1007\/s10157-011-0492-3","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,1]]}}}